Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

1–25 of 807 articles for sequence periodicity

Then save them, add them to a collection or cite them together.
  1. Research article · 2016

    Bioequivalence of Ipratropium Bromide HFA pMDI 20 μg/actuation in Healthy Volunteers with and without Charcoal Blockade and with Spacer Device

    Journal of Bioequivalence & Bioavailability · Volume 8, Issue 4

    charcoal blockade; and with spacer device. Study-1 was single dose, randomized, 4-period, 2‑sequence, laboratory-blinded, crossover, replicate design conducted in 90 healthy volunteers under fasting conditions with…

  2. Research article · 15 Feb 2023

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Single Dose, Cross Over, Bioequivalence Study of Bosutinib 100 Mg Tablets of Abbott Laboratories Versus Bosulif (Bosutinib) 100 Mg Film Coated Tablets of Pfizer Limited Under Fed Condition in Healthy Subjects

    Journal of Bioequivalence & Bioavailability · Volume 15, Issue 1

    Pfizer Limited in healthy subjects. An open label, balanced, randomized, two treatments, two sequences, two periods, single dose, cross over study with washout period of 07 days under fed condition

  3. Research article · 19 Dec 2022

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Four Periods, Fully Replicate, Crossover, Bioequivalence Study of Abiraterone Acetate 250 mg Tablets of Abbott Laboratories De Colombia Versus ZYTIGA® (Abiraterone Acetate) 250 mg Tablets of Janssen Biotech, Inc. Under Fasting Condition in Healthy Subjects

    Journal of Bioequivalence & Bioavailability

    fasting condition in healthy subjects. An open label, balanced, randomized, two treatments, two sequences, four periods, fully replicate, cross-over single dose study with washout period of 02 days under

  4. Research article · 28 Jun 2023

    An Open Label, Balanced, Randomized, Two Treatments, Three Sequences, Three Periods, Single Dose, Semi-Replicate, Crossover, Oral Bioequivalence Study of Palbociclib 125 Mg Capsules of Abbott Laboratories De Colombia Versus Ibrance (Palbociclib) 125 Mg Capsules of Pfizer in Healthy, Adult, Human Subjects Under Fed Conditions

    Journal of Bioequivalence & Bioavailability · Volume 15, Issue 3

    Pfizer in healthy subjects. An open label, balanced, randomized, two treatments, three sequences, three periods, single dose, semi replicate, cross over with washout period of 10 days under fed condition

  5. Research article · 31 Jan 2023

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Single Dose, Cross Over, Oral Bioequivalence Study of Vildagliptin 50 Mg Tablets of Abbott Laboratories De Colombia vs. Jalra (Vildagliptin) 50 Mg Tablets of Novartis Pharma Stein Ag, in Healthy, Adult, Human Subjects Under Fasting Condition

    Journal of Bioanalysis & Biomedicine · Volume 15, Issue 1

    healthy subjects under fasting condition. An open label, balanced, randomized, two treatments, two sequences, two periods, single dose, cross over study with washout period of 03 days under fasting condition

  6. Article · 13 Oct 2023

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Crossover, Single Dose, Bioequivalence Study of Olmesartan medoxomil/Hydrochlorothiazide 20 mg/12.5 mg Coated Tablets of Abbott and Olmetec plusandreg;andnbsp;(Olmesartan medoxomil/Hydrochlorothiazide) 20 mg/12.5 mg Coated Tablets of Daiichi-Sankyo in Healthy, Adult, Human Subjects Under Fasting Condition

    Journal of Bioequivalence & Bioavailability · Volume 15, Issue 5

    healthy, adult, human subjects. An open label, balanced, randomized two treatments, two sequences, two periods, crossover, single dose study with washout period of 02 days under fasting condition was carried

  7. Research article · 5 Oct 2023

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Crossover, Single Dose, Bioequivalence Study of Olmesartan Medoxomil/Hydrochlorothiazide 40 mg/12.5 mg Coated Tablets of Abbott and Olmetec Plus® (Olmesartan Medoxomil/Hydrochlorothiazide) 40 mg/12.5 mg Coated Tablets of Daiichi-Sankyo in Healthy, Adult, Human Subjects Under Fasting Condition

    Journal of Bioequivalence & Bioavailability · Volume 15, Issue 4

    healthy, adult, human subjects. An open label, balanced, randomized two treatments, two sequences, two periods, crossover, single dose study with washout period of 02 days under fasting condition was carried

  8. Research article · 5 Oct 2023

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Crossover, Single Dose, Oral Bioequivalence Study of Femelle 20 (Drospirenone 3 Mg and Ethinyl Estradiol 0.02 Mg) Coated Tablets of Abbott and Yaz® (Drospirenone 3 Mg And Ethinyl Estradiol 0.02 Mg) Coated Tablets of Bayer in Healthy, Adult, Human Female Subjects Under Fasting Condition

    Journal of Bioequivalence & Bioavailability · Volume 15, Issue 4

    healthy non-pregnant female subjects. An open label, balanced, randomized, two treatments, two sequences, two periods, crossover, single dose study with washout period of 14 days was carried

  9. Research article · 28 Mar 2022

    Levetiracetam Coated Tablet: A Randomized, Single-Dose, Two-Sequence, TwoPeriod, Crossover Study to Assess the Bioequivalence between Two Formulations

    Journal of Bioequivalence & Bioavailability · Volume 14, Issue 3

    regulatory requirements for marketing in Brazil. An open-label, randomized, single-dose, two-period, two-sequence, two-treatment crossover study was conducted in Brazilian healthy subjects of both genders. Subjects…

  10. Conference abstract

    Bioequivalence of Fixed-Dose Repaglinide/Metformin Combination Tablet and Equivalent Doses of Repaglinide and Metformin Tablet: A Randomized, Single-Dose, Two-Period, Two-Sequence Crossover Study in Healthy Korean Male V

    Journal of Clinical & Experimental Pharmacology

    tablet or EDI tablets after a 12-hour overnight fast in each period. Plasma concentrations of repaglinide and metformin up to 24 hours were determined using a UPLC ... Food and Drug Administration. Tolerability was…

  11. Article · 23 Nov 2024

    A Comparative Pharmacokinetic Evaluation of Paliperidone Palmitate Extended-Release Injectable Suspensions: An Open Label, Randomized, Two treatment, Two-Period, Two-Sequence, Multiple Dose, Steady State Crossover Bioequivalence Study in Patients with Schizophrenia and/or Schizoaffective Disorder

    Neuropsychiatry · Volume 14, Issue 5

    disorder. Methods: This open-label, multi-center, randomized, two-treatment, two-period, two-sequence, steady-state, cross-over, multiple-dose bioequivalence study enrolled 108 patients. Patients received…

  12. Research article · 8 Sep 2022

    Ketorolac Tromethamine Sublingual Tablet: A Randomized, Single-Dose, Two-Sequence, Two-Period, Crossover Study to Assess the Bioequivalence between Two Formulations

    Journal of Bioequivalence & Bioavailability · Volume 14, Issue 8

    ethical principles and current legislation, presenting an open, randomized, with two treatments, two periods and two sequences crossover design. For this study, 32 healthy men and women were selected; however

  13. Research article · 2011

    Bioavailability of Two Oral-Suspension Formulations of a Single Dose of Nitazoxanide 500 mg: An Open-Label, Randomized-Sequence, Two-Period Crossover, Comparison in Healthy Fasted Mexican Adult Volunteers

    Journal of Bioequivalence & Bioavailability · Volume 3, Issue 3

    bioavailability of this drug on the Mexican population. This single-dose, randomized-sequence, open-label, 2-period crossover study was conducted on a total of 26 Mexican adult subjects

  14. Conference abstract

    Bioequivalence and pharmacokinetic comparison between extended release capsules of carvedilol phosphate 40 mg: An open label, balanced, randomized-sequence, single-dose, two-period crossover study in healthy male volunte

    Journal of Bioequivalence & Bioavailability

    open-labeled, balanced, single-dose, two treatment, two period, two sequence, randomized two way crossover study was conducted in 18 healthy adult male subjects to determine the pharmacokinetic, bioavailability…

  15. Research article · 3 May 2019

    Pharmacokinetic and bioequivalence comparison between ursodeoxycholic acid tablets 500mg: An open label, balanced, randomized-sequence, singledose, two-period crossover study in healthy male volunteers

    Der Pharmacia Lettre · Volume 7, Issue 10

    design of an open label, balanced, randomized, two-sequence, single dose, two way crossover study with a wash-out period of at least 7 days was used. An open-labeled

  16. Conference abstract · 10 Aug 2015

    Title:Bioequivalence comparison between two different formulations of alverine citrate 120mg capsules: an open label, balanced, randomized-sequence, single-dose, two-period crossover study in healthy male volunteers

    Journal of Pharmaceutical Care & Health Systems

    open-labeled, balanced, single-dose, 2-treatment, 2-period, 2-sequence, randomized crossover study was designed and conducted to determine the pharmacokinetic, bioavailability and bioequivalence of alverine citrate

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels